First Xarelto Trial Results In Win For The Defendants

May 25, 2017

On May 3, 2017, a federal jury in Louisiana found against a Xarelto plaintiff who claimed that the defendants, Johnson & Johnson (“J & J”) and Bayer AG, had inadequately warned him regarding the internal bleeding risk associated with Xarelto, a blood-thinning medication that has [...]

Continue Reading

$3M Paxil Labeling Verdict For Suicide Death

May 9, 2017

On April 20, 2017, a Chicago jury returned its verdict in the amount of $3 million in favor of a widow whose 57-year-old husband was a corporate attorney who committed suicide while taking a generic version of Paxil, by stepping into the path of a train on July 15, 2010. The defendant was GlaxoSmith[...]

Continue Reading

Xarelto Lawsuits Allege Undisclosed Risk of Internal Bleeding

April 27, 2017

More than 18,000 patients have filed lawsuits alleging that the blood-thinning medication Xarelto caused them to suffer internal bleeding, the risk of which they allege was not disclosed to them. Johnson & Johnson and Bayer jointly developed Xarelto, which was approved by the FDA in 2011 to be u[...]

Continue Reading

Maryland Warns Against Use Of Nurse Assist Saline Flush Syringes

October 9, 2016

The Maryland Department of Health and Mental Hygiene (DHMH) announced on October 4, 2016 that it was issuing a recommendation that any healthcare facilities, providers or anyone else who has received Nurse Assist prepackaged, three-, five- and 10-milliliter syringes of saline flush immediately disc[...]

Continue Reading

$70M Risperdal Verdict

July 25, 2016

On July 1, 2016, a Philadelphia jury returned its verdict in the amount of $70 million against Janssen Pharmaceuticals, Inc., which manufactures the antipsychotic medication Risperdal. The Philadelphia verdict is the largest verdict so far in the mass tort litigation involving Risperdal claims that [...]

Continue Reading

Zofran Lawsuit Alleges Serious Birth Defects

November 12, 2015

On September 29, 2015, a federal lawsuit was filed in California by the parents of a child born with a serious heart defect that they contend was caused by the mother’s off-label use of Zofran that was prescribed by her doctor for nausea during her pregnancy. The defendant is GlaxoSmithKline [...]

Continue Reading

First Risperdal Trial In Philadelphia Results In $2.5M Verdict

March 8, 2015

On February 24, 2015, a Philadelphia jury returned its verdict in favor of the plaintiff in the amount of $2.5 million in the first of about 1,250 pending Risperdal cases to go to trial in Philadelphia. The month-long trial was followed by about one and a half days of jury deliberations before 11 o[...]

Continue Reading

1 2